Virios Therapeutics   Report issue

For profit Phase 2
Founded: Tuscaloosa AL United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2013
NCT01850420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Virios Therapeutics, Inc.